Published in J Bone Miner Res on September 01, 1997
Tumor localization and biochemical response to cure in tumor-induced osteomalacia. J Bone Miner Res (2013) 1.16
Tumor-induced osteomalacia caused by primary fibroblast growth factor 23 secreting neoplasm in axial skeleton: a case report. Case Rep Endocrinol (2012) 0.95
Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) 0.92
En bloc resection for treatment of tumor-induced osteomalacia: a case presentation and a systematic review. World J Surg Oncol (2015) 0.78
Reports of 17 Chinese patients with tumor-induced osteomalacia. J Bone Miner Metab (2016) 0.77
Following the forgotten phosphorus. Am J Med (2009) 0.75
Tumor induced osteomalacia secondary to anaplastic thyroid carcinoma: A case report and review of the literature. Bone Rep (2016) 0.75
MicroRNA expression in a phosphaturic mesenchymal tumour. Bone Rep (2017) 0.75
Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet (1982) 6.40
PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science (1996) 6.33
Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab (1983) 3.27
Purification and biological activity of thymosin, a hormone of the thymus gland. Proc Natl Acad Sci U S A (1972) 3.24
Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci U S A (1998) 3.24
Skeletal disease in primary hyperparathyroidism. J Bone Miner Res (1989) 3.00
Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet (2001) 2.93
Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant (2008) 2.63
Studies of factors involved in the production of low tension glaucoma. Arch Ophthalmol (1973) 2.49
Anabolic actions of parathyroid hormone on bone. Endocr Rev (1993) 2.13
Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J Cell Biol (1994) 2.00
Mutation leading to increased sensitivity to chromium in Salmonella typhimurium. J Bacteriol (1966) 1.99
Resistance to bone resorbing effects of PTH in black women. J Bone Miner Res (1997) 1.98
MR imaging of Baker cysts: association with internal derangement, effusion, and degenerative arthropathy. Radiology (1996) 1.97
Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology (2000) 1.93
Parathyroid hormone-related peptide delays terminal differentiation of chondrocytes during endochondral bone development. Endocrinology (1996) 1.86
Patellar height on sagittal MR imaging of the knee. AJR Am J Roentgenol (1996) 1.80
MR imaging of displaced bucket-handle tear of the medial meniscus. AJR Am J Roentgenol (1991) 1.75
Nucleolar localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death. Mol Cell Biol (1995) 1.73
1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis. Lancet (1979) 1.71
Targeted overexpression of parathyroid hormone-related protein (PTHrP) to vascular smooth muscle in transgenic mice lowers blood pressure and alters vascular contractility. Endocrinology (1999) 1.64
Influence of thymosin on cell-mediated and humoral immune responses in normal and in immunologically deficient mice. J Immunol (1970) 1.62
Cell-specific signal transduction of parathyroid hormone (PTH)-related protein through stably expressed recombinant PTH/PTHrP receptors in vascular smooth muscle cells. Endocrinology (1996) 1.61
The flipped meniscus sign. Skeletal Radiol (1993) 1.57
On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab (1999) 1.53
1 alpha,25-dihydroxyvitamin D3 induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor. J Clin Invest (1984) 1.52
Parathyroid hormone-related protein is required for tooth eruption. Proc Natl Acad Sci U S A (1998) 1.52
Availability, utilization and outcomes of deceased diabetic donor kidneys; analysis based on the UNOS registry. Am J Transplant (2012) 1.52
Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy. Osteoporos Int (2009) 1.52
The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab (1990) 1.51
Diphosphonate therapy of paget's disease of bone. J Clin Endocrinol Metab (1977) 1.50
Psychiatric study of a consecutive series of 34 patients with ulcerative colitis. Br Med J (1967) 1.48
Programmed cell death of chondrocytes and aberrant chondrogenesis in mice homozygous for parathyroid hormone-related peptide gene deletion. Endocrinology (1996) 1.46
Liquid crystal contact thermography of deep venous thrombosis. AJR Am J Roentgenol (1982) 1.44
Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism. Bone (2007) 1.43
Parathyroid hormone-related peptide (PTHrP) regulates fetal-placental calcium transport through a receptor distinct from the PTH/PTHrP receptor. Proc Natl Acad Sci U S A (1996) 1.42
Exogenous calciferol (vitamin D) and vitamin D endocrine status among elderly nursing home residents in the New York City area. J Am Geriatr Soc (1993) 1.42
Constant mineralization density distribution in cancellous human bone. Bone (2003) 1.41
The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med (1999) 1.40
Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med (1990) 1.39
Acquired systemic tolerance to rat cardiac allografts induced by intrathymic inoculation of synthetic polymorphic MHC class I allopeptides. Transplantation (1996) 1.38
Interaction of calcium nutrition and physical activity on bone mass in young women. J Bone Miner Res (1988) 1.37
Relationship of the meniscofemoral ligaments of the knee to lateral meniscus tears: magnetic resonance imaging evaluation. Am J Orthop (Belle Mead NJ) (1998) 1.37
Histomorphometric assessment of bone mass, structure, and remodeling: a comparison between healthy black and white premenopausal women. J Bone Miner Res (1997) 1.36
The role of angiogenesis in a murine tibial model of distraction osteogenesis. Bone (2004) 1.31
Intra- and extraosseous malignant histiocytoma (malignant fibrous xanthoma). Radiology (1972) 1.31
Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development. Dev Biol (1996) 1.31
Identical complementary deoxyribonucleic acids encode a human renal and bone parathyroid hormone (PTH)/PTH-related peptide receptor. Endocrinology (1993) 1.31
Vitamin D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr (1985) 1.30
Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest (1998) 1.30
Vitamin-D synthesis and metabolism after ultraviolet irradiation of normal and vitamin-D-deficient subjects. N Engl J Med (1982) 1.29
Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial. Osteoporos Int (2014) 1.29
Effect of pH on bone resorption by rat osteoclasts in vitro. Endocrinology (1986) 1.26
Parathyroid hormone-related protein as a growth regulator of prostate carcinoma. Cancer Res (1999) 1.24
Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis. J Bone Miner Res (1992) 1.23
A radioimmunoassay for 1,25-dihydroxycholecalciferol. Clin Sci Mol Med (1978) 1.22
The uncoupled extrusion of Na+ through the Na+ pump. Biochim Biophys Acta (1973) 1.21
Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcif Tissue Int (1983) 1.21
MR imaging of the knee: clarification of its role. Arthroscopy (1991) 1.20
Serum vitamin D2 and vitamin D3 metabolite concentrations and absorption of vitamin D2 in elderly subjects. J Clin Endocrinol Metab (1986) 1.18
Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynecol (1990) 1.17
"Epileptic" brain damage is replicated qualitatively in the rat hippocampus by central injection of glutamate or aspartate but not by GABA or acetylcholine. Brain Res Bull (1985) 1.16
Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. Br J Pharmacol (2001) 1.15
Kidneys at higher risk of discard: expanding the role of dual kidney transplantation. Am J Transplant (2014) 1.15
Laboratory identification and epidemiology of streptococcal hospital isolates. J Clin Microbiol (1978) 1.15
A novel respiration-deficient mutant of Saccharomyces cerevisiae. I. Preliminary characterization of phenotype and mitochondrial inheritance. J Biol Chem (1974) 1.15
Localization of rat cathepsin K in osteoclasts and resorption pits: inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones. Biol Chem (1999) 1.14
Psychiatric study of a consecutive series of 19 patients with regional ileitis. Br Med J (1967) 1.14
Early catheter removal decreases incidence of urinary tract infections in renal transplant recipients. Transplant Proc (1998) 1.14
Radioimmunoassay of 1,25-dihydroxy vitamin D2: studies on the metabolism of vitamin D2 in man. Clin Endocrinol (Oxf) (1983) 1.13
Hypoxia induces vascular endothelial growth factor gene transcription in human osteoblast-like cells through the hypoxia-inducible factor-2alpha. Endocrinology (2001) 1.13
Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. Q J Med (1984) 1.13
A comparative study of disaggregated chick and rat osteoclasts in vitro: effects of calcitonin and prostaglandins. Endocrinology (1987) 1.12
Selective intra-arterial embolization of bone tumors. A useful adjunct in the management of selected lesions. Am J Roentgenol Radium Ther Nucl Med (1975) 1.11
End-organ resistance to 1,25-dihydroxycholecalciferol. Lancet (1980) 1.09
Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats. J Bone Miner Res (1996) 1.09
Zinc is a potent inhibitor of osteoclastic bone resorption in vitro. J Bone Miner Res (1995) 1.09
Defects in articular cartilage metabolism and early arthritis in fibroblast growth factor receptor 3 deficient mice. Hum Mol Genet (2006) 1.09
Absorptive function in canine jejunal autografts and allografts. Surgery (1969) 1.08
Cloning of human PEX cDNA. Expression, subcellular localization, and endopeptidase activity. J Biol Chem (1998) 1.08
Circulating osteogenic precursor cells in type 2 diabetes mellitus. J Clin Endocrinol Metab (2012) 1.08
CT scans through metal scanning technique versus hardware composition. Comput Med Imaging Graph (1995) 1.07
Occupational influences on retirement, disability, and death. Demography (1989) 1.07
Daily assessment of ocular and hormonal variables throughout the menstrual cycle. Arch Ophthalmol (1978) 1.07
Meniscal position on routine MR imaging of the knee. Skeletal Radiol (1997) 1.07
Immunocytochemical localization of the 1,25-dihydroxyvitamin D3 receptor in target cells. Endocrinology (1988) 1.06
Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat. J Bone Miner Res (2001) 1.05
The NCIC-Manitoba Breast Tumor Bank: a resource for applied cancer research. CMAJ (1996) 1.05
Interaction of 1,25-dihydroxyvitamin-D3 with keratinocytes and fibroblasts from skin of normal subjects and a subject with vitamin-D-dependent rickets, type II: a model for study of the mode of action of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab (1983) 1.05
Silica Sep-Pak preparative chromatography for vitamin D and its metabolites. J Chromatogr (1981) 1.05
Measurement of 1,25-dihydroxycholecalciferol in man by radioimmunoassay. Clin Endocrinol (Oxf) (1979) 1.05
Biological activities of glucagon-like peptide-1 analogues in vitro and in vivo. Biochemistry (2001) 1.04